These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Potentialities of synchrotron radiation in experimental and clinical radiation surgery. Larsson B Acta Radiol Suppl; 1983; 365():58-64. PubMed ID: 6433653 [No Abstract] [Full Text] [Related]
43. Biological weighting of absorbed dose in radiation therapy. Wambersie A; Menzel HG; Gahbauer RA; Jones DT; Michael BD; Paretzke H Radiat Prot Dosimetry; 2002; 99(1-4):445-52. PubMed ID: 12194351 [TBL] [Abstract][Full Text] [Related]
44. Experimental tests of proton beam localization. Bennett GW; Archambeau JO Med Phys; 1977; 4(2):115-7. PubMed ID: 850507 [TBL] [Abstract][Full Text] [Related]
45. Radiation protection at high energy proton accelerators. Silari M; Stevenson GR Radiat Prot Dosimetry; 2001; 96(4):311-21. PubMed ID: 11843081 [TBL] [Abstract][Full Text] [Related]
46. The biological effect of very high energy hadrons. Baarli J; Bianchi M; Diehl-Marshall I; Raffnsøe RC; Riedel M; Sotirious D; Sullivan AH; Tuyn JW Int J Radiat Biol Relat Stud Phys Chem Med; 1981 May; 39(5):559-63. PubMed ID: 6972366 [TBL] [Abstract][Full Text] [Related]
47. Clinical gain from improved beam delivery systems. Castro JR; Petti PL; Daftari IK; Collier JM; Renner T; Ludewigt B; Chu W; Pitluck S; Fleming T; Alonso J Radiat Environ Biophys; 1992; 31(3):233-40. PubMed ID: 1502331 [TBL] [Abstract][Full Text] [Related]
48. Code of practice for x-ray therapy linear accelerators. Med Phys; 1975; 2(3):110-21. PubMed ID: 1186625 [No Abstract] [Full Text] [Related]
51. Single-beam radiotherapy knife. A practical theoretical model. Heifetz MD; Wexler M; Thompson R J Neurosurg; 1984 Apr; 60(4):814-8. PubMed ID: 6707750 [TBL] [Abstract][Full Text] [Related]
52. The application of nuclear magnetic resonance data to radiation therapy. Bloch P Comput Radiol; 1983; 7(3):195-8. PubMed ID: 6311484 [TBL] [Abstract][Full Text] [Related]
53. International collaboration may enhance proton therapy research. Antoine FS J Natl Cancer Inst; 1991 Jan; 83(1):9-10. PubMed ID: 1845815 [No Abstract] [Full Text] [Related]
54. Rekindling the immortal debate- telecobalt versus linear accelerator. Susheela SP; Revannasiddaiah S J Cancer Res Ther; 2015; 11(1):243-4. PubMed ID: 26058104 [No Abstract] [Full Text] [Related]
55. Proton beam therapy: reliability of the synchrocyclotron at the Harvard Cyclotron Laboratory. Sisterson JM; Cascio E; Koehler AM; Johnson KN Phys Med Biol; 1991 Feb; 36(2):285-90. PubMed ID: 1848941 [No Abstract] [Full Text] [Related]
56. The relative biological effectiveness of 160 MeV protons. I. Microdosimetry. Kliauga PJ; Colvett RD; Lam YM; Rossi HH Int J Radiat Oncol Biol Phys; 1978; 4(11-12):1001-8. PubMed ID: 102619 [No Abstract] [Full Text] [Related]
57. Radioactive and toxic gas production by a medical electron linear accelerator. Holloway AF; Cormack DV Health Phys; 1980 Apr; 38(4):673-7. PubMed ID: 7410085 [No Abstract] [Full Text] [Related]
58. Heavy charged particle radio therapy. Goitein M Z Med Phys; 2004; 14(1):1-3. PubMed ID: 15104004 [No Abstract] [Full Text] [Related]
59. Chamber replacement correction in absorbed dose calibrations. Burns JE Med Phys; 1992; 19(1):209-10; discussion 211. PubMed ID: 1620051 [No Abstract] [Full Text] [Related]
60. Determination of effective bombarding energies and fluxes using an improved stacked foil technique. Tárkányi F; Szelecsényi F; Takács S Acta Radiol Suppl; 1991; 376():72. PubMed ID: 1666789 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]